1. Medtech Insight

Ortho Roundup: Strong Knees Let SYK Stands Tall Against Recon Rivals ZMH, SNN And JNJ

 
• By Tina Tan

The top four orthopedic implant makers have released their second-quarter and half-year results. Following DePuy Synthes report of a still-soft but recovering reconstructive implant market, this edition of Earnings Winners And Losers look at how the other three big recon players – Zimmer Biomet, Stryker, and Smith & Nephew fare. It also offers a peek into the top- and bottom-line results of the other key names within Medtech Insight's Top 10 orthopedic companies.

Hips

Commenting on DePuy Synthes' year-over-year decline in its second quarter results, Johnson & Johnson CEO Alex Gorsky acknowledged that there was still some work to be done to get the orthopedics leader back to positive growth. Knees, in particular, are giving the company trouble, but Gorsky assured investors that that half of the recon business was actually improving from the first-quarter. (Also see "Earnings Winners & Losers: ISHG Beats Forecasts; JNJ Ortho Sales Still Soft; ABT; DNH " - Medtech Insight, 26 July, 2018.)

Since JNJ released its results on July 17, the three other big ortho players – based on Medtech Insight's Top 10 Ortho league table - have also announced...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Orthopedics

More from Device Area